Sheila J M Ingham

1PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 06, 2022
Befovacimab, an anti-tissue factor pathway inhibitor antibody: Early termination of the multiple-dose, dose-escalating Phase 2 study due to thrombosis.

Maria Elisa Mancuso, Sheila J M Ingham, Marc Kunze

Pageof 1

Frequent Collaborators

1 joint publications

Maria Elisa Mancuso